Latest News and Events
Filter by
Selections
September 20, 2019
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Read MoreSeptember 16, 2019
Arrowhead Pharmaceuticals Presents Initial Top-Line Clinical Data and Preclinical Data on RNAi Candidates ARO-APOC3 and ARO-ANG3
Read MoreAugust 30, 2019
Arrowhead Pharmaceuticals to Participate in Upcoming September 2019 Conferences
Read MoreAugust 28, 2019
Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection
Read MoreAugust 8, 2019